English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/55690
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
DC FieldValueLanguage
dc.contributor.authorMéndez, J. A.-
dc.contributor.authorFernández, M.-
dc.contributor.authorGonzález-Corchón, A.-
dc.contributor.authorSalvado, M.-
dc.contributor.authorCollía, F.-
dc.contributor.authorPedro, J. A. de-
dc.contributor.authorLevenfeld, B. L.-
dc.contributor.authorLópez-Bravo, A.-
dc.contributor.authorVázquez Lasa, Blanca-
dc.contributor.authorSan Román, Julio-
dc.date.accessioned2012-09-06T10:34:12Z-
dc.date.available2012-09-06T10:34:12Z-
dc.date.issued2004-
dc.identifier.citationBiomaterials 25 : 2381–2392 (2004)es_ES
dc.identifier.issn0142-9612-
dc.identifier.urihttp://hdl.handle.net/10261/55690-
dc.description.abstractInjectable bioactive acrylic formulations based on poly(methyl methacrylate) (PMMA) and different amounts of bioactive glasses in the system SiO2–CaO–Na2O–P2O5 have been prepared in the presence of the anti-inflammatoryanalgesic drug fosfosal, the sodium salt of 2-phosphonoxibenzoic acid, to be used in minimallyinvasive surgery. The injectabilityof the formulations evaluated according to the established protocol was around 80%. The experimental formulations provided maximum temperatures in the range 50–60 C, which were lower than those of commercial acrylic bone cements currently used in percutaneous vertebroplasty (PVP). Residual monomer content of anyformulation was inferior to 5%. Compressive yield strength of dryspecimens was in the range 80–95 MPa, but it decreased after immersion in SBF to values in the range 30–50 MPa, due to the dissolution of the bioactive glasses and the drug in the medium. The release of fosfosal was evaluated in vitro (pH ¼ 7:0). The release profile against time obtained from a PMMA cement was quasi-linear and the 80% of the initial amount of drug was released in 175 h. However, for bioactive cements, the 80–100% of the fosfosal charged was released in approximately48 h, due to the dissolution of the glasses in the medium. Values of weight loss of the cements determined gravimetricallyranged between 16% and 26% depending on the initial amount of fosfosal, i.e. 20 or 30 wt%, respectively. The weight loss and the water uptake were simultaneous processes, and values of hydration degree were around 10–14%. The formation of an apatite-like layer was detected on the surface of the cements at different periods of time depending on the composition of the bioactive glasses. The cements containing the glasses with P2O5 produced the growth of the apatite layer in shorter periods of time. The presence of fosfosal accelerated the precipitation of this layer independentlyon the glasses. The in vivo biocompatibilitystudied byintramuscular implantation in rats showed the absence of an anti-inflammatoryresponse and a fibrous layer around the implant for the cement prepared with PMMA/fosfosal which is attributed to the therapeutic action of fosfosal acting in situ. The response to cements prepared with bioactive glasses and fosfosal showed a mild inflammatoryreaction with the formation of the typical fibrous capsule around the implanted materiales_ES
dc.description.sponsorshipFinancial support from the Comisi ! on Interministerial de Ciencia y Tecnologia, CICYT (MAT2002-04147-C02- 02) is grateful acknowledged. The authors wish to thank Fco Javier Muñoz-González and Javier Jiménez Amibas for sample preparation in the histological examination.es_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsclosedAccesses_ES
dc.subjectPMMAes_ES
dc.subjectBioactive bone cementes_ES
dc.subjectBioactive glasses_ES
dc.subjectFosfosales_ES
dc.subjectHydroxyapatitees_ES
dc.titleInjectable self-curing bioactive acrylic-glass composites charged with specific anti-inflammatory/analgesic agentes_ES
dc.typeartículoes_ES
dc.identifier.doi10.1016/j.biomaterials.2003.09.004-
dc.description.peerreviewedPeer reviewedes_ES
dc.relation.publisherversionhttp://dx.doi.org/10.1016/j.biomaterials.2003.09.004es_ES
dc.contributor.funderComisión Interministerial de Ciencia y Tecnología, CICYT (España)-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100007273es_ES
Appears in Collections:(ICTP) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show simple item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.